Nexalis Therapeutics Limited has released a press release.
Sep25 Appendix 4C Cash Flow Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Nexalis Therapeutics Limited on 6ix
Story so far
Earlier from Nexalis Therapeutics
- Half Yearly Report and Accounts
- Jun25 Quarterly Activities Report
- Jun25 Appendix 4C Cash Flow Report
- Mar25 Quarterly Activities Report
- Mar25 Appendix 4C Cash Flow Report
Later from Nexalis Therapeutics
- Sep25 Quarterly Activities Report
- Trading Halt
- Drug Development Pipeline Bolstered and Capital Raise
- Prospectus - Non-Renounceable Rights Issue Offer
- $12.6m Facility to Drive SRX-25 Development
Follow Nexalis Therapeutics into a list and get an email when it puts out news.
Follow Nexalis Therapeutics